多元•前沿•深入——2015 SLAS亚洲会展

多元•前沿•深入——2015 SLAS亚洲会展

2015/04/09-2015/04/10
上海
3014人浏览过

活动简介

相关报道

多元•前沿•深入——2015 SLAS亚洲会展

第三届SLAS亚洲年会及展会将由会展实验室自动化与筛选协会(SLAS) — 将于2013年6月5日—7日在上海金茂君悦大酒店举办。今年年会将围绕“药物研发和实验室技术”这一主题展开,并由来自美国总统巴拉克•奥巴马的科学与技术顾问委员会委员Chad A. Mirkin博士,及科技部创新基金获得者丁列明,汇同众多国内外知名药物研发专家,为您带来一场全新的科技盛宴!
活动背景

多元•前沿•深入——2015 SLAS亚洲会展

第四届SLAS亚洲会展将于2015年4月9日-10日在上海世纪皇冠假日酒店举行。本届大会主题为“Come Transform Research”。中科院院士高福、饶子和、王晓东等多位学术界知名科学家携手跨国药企、CRO和技术服务企业的科研人员及高管,担任本届大会演讲嘉宾。他们将从小分子、天然产物、大分子等不同角度出发,和参会者共同探讨新药发现的最新研究成果及技术创新。内容包含靶标确认、高通量筛选、转化医学、抗体研究等热门主题。多样化的研究领域和方向将使得本次大会精彩纷呈。

本届大会不仅从多元化角度为参会者们呈现新药发现领域的前沿科学性内容。同时,还将以实例跟大家分享学术产业界的合作如何促进科学研究成果的转化。在为期两天的同期展会中,三十多家跨国公司将展示最新实验室自动化仪器和相关技术。本届大会也是SLAS与生物医药创新社的首次合作,其2015年会将于4月10日同期召开。

SLAS会员将享受免费参会资格(需同时加入两个分部:BSS和LAS),普通参会人员在2015年1月31日前可享受早期注册优惠价650元。现参会者可登陆会议官方网站2015.asia-slas.org进行会议注册。

会议日程

多元•前沿•深入——2015 SLAS亚洲会展

Day 1, Thursday, 9 April
08:45-09:00SLAS Opening Remarks
09:00-09:45Keynote 1: TBC
Barry Sharpless (tbc)
09:45-12:45Session 1: Leading Science for Small Molecules Drug Discovery
Co-chairs: 

Jonathan Connick, Executive Director, Head External in Vitro Pharmacology. Site Head, EDDS and PCD China, Merck & Co Inc., Member of SLAS Asia Council
Bin Li, R&D Director, AbbVie China R&D Center, Secretary of SLAS Asia Council
09:45-10:15Topic tbc
Ray Steven (GPCR Consortium), i-Human  
10:15-10:45Phenotypic Drug Discovery and Target Deconvolution
Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL)
10:45-11:15Break in Exhibit Hall
11:15-11:45Discovery of HIV Integrase Inhibitors
John Wai, Vice President, WuXi Apptec
11:45-12:45Panel Discussion
Moderator: Jonathan Connick, Executive Director, Head External in Vitro
Pharmacology. Site Head, EDDS and PCD China, Merck & Co Inc., Member of SLAS Asia Council
Panelist: 
Pharma – Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL)
CRO - Xuehai Tan, CEO & President, HD Biosciences Co., Ltd.
Technology Provider - Joe Gu, LST APAC VP GM, Perkin Elmer
Academia – panelist (tbc)
12:45-14:30Lunch in Exhibit Hall
12:45-14:30Posters
13:30-14:15Exhibitor Tutorial 1Exhibitor Tutorial 2
14:30-17:00Session 2: Natural Product Drug Discovery & Synthetic Biology
Co-chairs:

Bing Xie, Managing Director, Asia Pacific, Cisbio, Member of SLAS Asia Council
Mike Zhang, Associate Sales Director, Research, BD Biosciences, Member of SLAS Asia Council
14:30-15:00Discovery of NITD609 as Antimalarial: From Natural Product-like Lead to Clinical Candidate
Bin Zou, Senior Medicinal Chemist, Novartis Institute for Tropical Diseases (Singapore)
15:00-15:30HTS Hits - Which Should You Discard, and Why?
Jonathan Baell, Research Professor, Medicinal Chemistry, Monash Institute of Pharmaceutical Science
15:30-16:00Break in Exhibit Hall
16:00-16:30Anti-infective and Anti-tumor Natural Products Discovery and Biosynthesis from marine Actinomycetes
Jianhua Ju, Professor, South China Sea Institute of Oceanology, Chinese Academy of Sciences; Director, Guangdong Key Laboratory of Marine Materia Medica; Deputy Director, CAS  Key Laboratory of Marine Bio-resources and Ecology
16:30-17:00Anti-infectious Natural Products from Marine-derived Microbes
Xueting Liu, Associate Professor , CAS Key Laboratory of Pathogenic Microbiology & Immunology
17:00-17:30Topic tbc
Hakim Djaballah - tbc
17:30-19:00Reception
Day 2,Friday, 10 April
Biologics Enabling Working Group 2015 Annual Conference
08:45-09:00Welcome Speech- Biologics Enabling Working Group Annual Conference 
Prof.    Richard Lerner
, Immunochemist; Professor & Former President, The Scripps Research Institute; Academician, American National Academy of Sciences; Founding Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
09:30-12:45Session 3: The Scientific Frontier of Biological Discovery
Part ICo-chairs:
Ying Yang, Founder & CEO, LBD Life Sciences Ltd; Asia Council Chair, Society for Laboratory Automation and Screening (SLAS) 
Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
09:00-09:30Keynote 2 : Vaccine and Therapeutic Antibody for New Outbreak of Pathogen
Fu Gao, Vice President, Beijing Institutes of Life Science, Chinese Academy of Sciences; Director, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology; Professor, University of Science and Technology of China
09:30-10:00Virus and Anti-Virus Drug Discovery
Zihe Rao, Biophysicist & Structural Biologist; Professor & Former President, Nankai University; Academician, Chinese Academy of Sciences; President, Biophysical Society of China; President, International Union of Pure and Applied Biophysics (IUPAB)
10:00-10:30Topic tbc 
Speaker tbc
10:30-11:00Break in Exhibit Hall
Part IICo-Chairs:
Guang Yang, Vice Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
Mingqiang Zhang, Vice President, R&D for China Amgen
11:00-11:30Systems Approach to Translational Medicine
Genghong Chen, Director, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; Professor, Department of Microbiology, Immunology & Molecular Genetics, UCLA
11:30-12:00Therapeutic Antibody Discovery and Lead Selection
Yan Wu, Associate Director, Genentech
12:00-12:45Feature  Talk and Panel Discussion: Case Study-NIBS’s    Technology Transfer and Commercialization of Scientific Findings
Moderator: Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co.
Speaker: Xiaodong Wang, Biochemist; Director & Investigator, National Institute of Biological Science, China; Member, National Academy of Sciences, USA
Panelist:
Mingqiang Zhang, Vice President of R&D for China Amgen
Yajun Xu, SVP & Chief Investment Officer, ChemPartner
Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
12:45-14:00Lunch in Exhibit Hall
12:45-14:00Posters
13:15-14:00Exhibitor Tutorial 3:
To be defined
Exhibitor Tutorial 4:
To be defined
14:00-17:30Session 4: ADC - From Technology, Process, Discovery to Development (To be confirmed)
Part ICo-chairs:
Xueming Qian, Chairman & CEO, Mabspace Bioscience
Yajun Xu, SVP & Chief Investment Officer, ChemPartner
14:00-14:30R&D of Antibody – Drug Conjugates: Strategy and Perspectives
Weikang Tao, CSO, Hengrui Pharmaceutical R&D
14:30-15:00Site Specific Conjugation: Improvement of ADC Homogeneity and Druggability Properties
Bruce Nianhe Han, CSO, NewBio Therapeutics 
15:00-15:30R&D of Next-generation ADCs Based on LDC Technology
Gang Qin, CEO, GeneQuantum Healthcare (Suzhou) Co., Ltd.
15:30-16:00Biological Characterization of Antibody Drug Conjugates
Mary Hu, CEO, Shanghai Miracogen Inc
16:00-16:30Break in Exhibit Hall
Part IICo-chairs:
Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation (New York); President, Kadmon China
Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co.
16:30-17:00A New Generation of Antibody-drug Conjugates for the Targeted Treatment of Cancer
Robert Yongxin Zhao, CEO & Chairman, Hangzhou DAC Biotech Co., Ltd. 
17:00-17:30Ambrx story - Topic tbc
Chris Chen, Head of Biologics, Wuxi Apptec
17:30-17:45Closing Remark (awarding)
关于SLAS

多元•前沿•深入——2015 SLAS亚洲会展

作为推动科学与技术相结合的平台,实验室自动化与筛选协会(Society for Laboratory Automation and Screening, SLAS)聚集了来自全球的18000名生命科学领域的研发精英,包括科学家、技术提供商、研究人员、学术人员和学生、工程师、信息学专家以及商业领袖。SLAS组织并提供全年的教育和交流活动,致力于为全球科学和技术领域的专业人员建立联系并达成合作创新。

SLAS于2010年由生物分子科学协会(SBS)和实验室自动化协会(ALA)合并成立,并于2011下半年正式成立了亚洲办事处(www.asia-slas.org)。2013年12月,SLAS亚洲理事会正式成立,由七名委员组成,他们来自于行业和学术领域的不同机构。亚洲理事会的主要职责是立足于本区域的需求对SLAS在区域内的发展进行规划和决策。

联系方式

多元•前沿•深入——2015 SLAS亚洲会展

REGISTRATION

Email:Registration@asia-slas.org

Tel: 86-21-2312 3576 (10:00 A.M.- 18:00 P.M.)

SPONSORSHIP & EXHIBITION

Email:czhang@slas.org

Tel: 86-21-2312 3587 (10:00 A.M.- 18:00 P.M.)

ASIA OFFICE

Email:asia@slas.org

Tel: 86-21-2312 3644 (10:00 A.M.- 18:00 P.M.)

会议地址

多元•前沿•深入——2015 SLAS亚洲会展

分享这个活动


扫描以上二维码
分享到社交网络